<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Bulletin of Semashko National Research Institute of Public Health</journal-id><journal-title-group><journal-title>Bulletin of Semashko National Research Institute of Public Health</journal-title></journal-title-group><issn publication-format="print">2415-8410</issn><issn publication-format="electronic">2415-8429</issn><publisher><publisher-name>FSSBI «N.A. Semashko National Research Institute of Public Health»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2446</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Managing the availability of blood components for patients undergoing surgery under a cardiopulmonary bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Fatkhullina</surname><given-names>L. S.</given-names></name><bio></bio><email>lusik65@rambler.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dzhordzhikiya</surname><given-names>R. K.</given-names></name><bio></bio><email>roink@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roshchin</surname><given-names>D. O.</given-names></name><bio></bio><email>droshchin2@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Interregional Clinic and Diagnostic Center</aff><aff id="aff-2">N. A. Semashko National Research Institute of Public Health</aff><pub-date date-type="epub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><issue>3</issue><fpage>11</fpage><lpage>15</lpage><history><pub-date date-type="received" iso-8601-date="2022-08-09"><day>09</day><month>08</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022,</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>Managing the availability of blood components in a multidisciplinary hospital providing surgical care is both determinant of quality treatment and safety risk. In this article the availability of blood components is considered within the context of high-tech medical care, including cardiopulmonary bypass surgery (CPB). The study was performed on the basis of Interregional Clinic and Diagnostic Center (hereinafter referred to as ICDC), which holds the predominant position in the Republic of Tatarstan in the area of high-tech medical care. ICDC is a top ten Russian medical centers by the number of medical cases. Currently, open-heart surgery under CPB is widespread. The prevention and treatment of hematologic disorders in correcting heart disease remains one of the contemporary challenges of trans-fusiology and cardiac surgery, despite the improvements in surgical techniques, the increasing development of perfusion science, and the growing possibilities of intensive care. A retrospective analysis of haemostasis in 160 patients operated under cardiopulmonary bypass in the cardiac surgery units of ICDC between 2017 and 2020 was carried out.</abstract><kwd-group xml:lang="en"><kwd>surgical care management</kwd><kwd>transfusiology</kwd><kwd>blood components</kwd><kwd>cardiac surgery</kwd><kwd>thrombocytopenia</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>организация хирургической помощи</kwd><kwd>трансфузиология</kwd><kwd>компоненты крови</kwd><kwd>кардиохирургия</kwd><kwd>тромбоцитопения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Бокерия Л. А. Болезни и врожденные аномалии системы кровообращения /Л. А. Бокерия, Р. Г. Гудкова. - М.: Научный центр сердечно-сосудистой хирургии им. А. Н. Бакулева, 2013. - 210 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Шевченко Ю. Л. Кардиохирургическая трансфузиология: Монография /Ю. Л. Шевченко, С. А. Матвеев, А. В. Чечеткин. - М.: Классик-Консалтинг, 2000. - 128 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Румянцев, А. Г. Клиническая трансфузиология /А. Г. Румянцев, В. А. Аграненк. - М.: ГЭоТаР Медицина, 1997. - 576 с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Данилов И. П. Тромбоциты: новый взгляд на их роль в организме /И. П. Данилов // Медицинские новости. - 2008. - №9. - С. 17-19.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Фатхуллина Л. С. Роль трансфузии концентрата тромбоцитов при кардиохирургических операциях /Л. С. Фатхуллина, Р. К. Джорджикия, Р. М. Мукминова, И. М. Рахимуллин и др. // Вестник современной клинической медицины. - 2014. - Том 7. - № 5. - С. 56-58.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Городецкий В. М. Трансфузионная коррекция нарушений системы гемостаза /В. М. Городецкий, Е. М. Шулутко, А. В. Кильдюшевский. - М.: МОНИКИ, 2017. - 55 с.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Точенов А. В. Физиология, механизмы регуляции и методы лабораторного исследования системного гемостаза /А. В. Точенов, А. В. Кильдюшевский, Л. И. Каюмова, Д. Е. Жемчугин. - М.: МОНИКИ, 2017. - 55 с.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Балуда В. П. Лабораторные методы исследования гемостаза /В. П. Балуда, З. С. Баркаган, Е. Д. Гольдберг. - Томск: Красное знамя, 1980. - 313 с.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Leahy M. F., Trentino K. M., May C. et al. Blood use in patients receiving intensive chrmotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. Transfusion. 2017, vol. 57, no. 8, pp. 2189-2196.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Helge J. W. Impact of blood donation on exercise tolerance. Vox Sanguinis. 2019, vol. 114, suppl. 1, pp. 8.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jansen P., Sumnig A., Esefeld M., Greffin K., et al. Well-being and return rate of first-time whole blood donors. Vox Sanguinis. 2019, vol. 114, no 2, pp. 154-161.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Hoogerwerf M. D., Veldhuizen I. J.T., Tarvainen M. P. Physiological stress response pattens during a blood donation. Vox Sanguinis. 2018, vol. 113, no 4, pp. 357-367.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Salvadori U., Sandri M., Cemin R., et al. Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions. Vox Sanguinis. 2019, vol. 114, no 4, pp. 317- 324.</mixed-citation></ref></ref-list></back></article>
